Skip to main content

Table 2 Prognostic elements stratified for outcome within 3 months

From: SSEP N20 and P25 amplitudes predict poor and good neurologic outcomes after cardiac arrest

 n = 82

CPC3–4–5

n = 64

CPC1–2

n = 18

p

CA-SSEP delay, days, median (IQR)

3 (2.5–4)

3 (2–4)

0.62

SSEP responses:

  

0.01

 Bilaterally absent «AA»

19 (30%)

0

 

 Unilaterally present «AP»

4 (6%)

0

 

 Bilaterally present «PP»

41 (64%)

18 (100%)

 

N20-Baseline amplitude (µV) of the «PP» patterns, median

0.93 (0–2.05)

1.56 (1.24–2.75)

0.008

N20–P25 amplitude (µV) of the «PP»

patterns, median

MD n = 3

0.57 (0–1.43)

2.64 (1.39–3.80)

 < 0.0001

NSE peak at day 2, median (µg/l)

96.5 (46–240)

29.5 (20–42)

 < 0.0001

NSE peak at day 3, median (µg/l)

157 (54–353)

21 (16–36)

 < 0.0001

Highly malignant EEG, n (%)

23 (34.4%)

0 (0%)

0.0021

Malignant EEG, n (%)

32 (50%)

2 (11%)

0.0029

Benign EEG, n (%)

9 (14%)

16 (89%)

 < 0.0001

Status myoclonus n (%)

36 (56.3%)

1 (5.6%)

 < 0.0001

  1. CA cardiac arrest, EEG electroencephalogram, MD missing data, NSE neurone specific enolase